![Christopher Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Christopher S.
Brennan is currently the Chief Operating Officer at Allucent.
Christopher Brennan active positions
Companies | Position | Start |
---|---|---|
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Christopher Brennan